Louis W Sullivan - Net Worth and Insider Trading

Louis W Sullivan Net Worth

The estimated net worth of Louis W Sullivan is at least $5 Million dollars as of 2024-03-29. Louis W Sullivan is the Director of United Therapeutics Corp and owns about 12,180 shares of United Therapeutics Corp (UTHR) stock worth over $3 Million. Louis W Sullivan is the Director of Henry Schein Inc and owns about 25,986 shares of Henry Schein Inc (HSIC) stock worth over $2 Million. Louis W Sullivan is also the Director of Emergent BioSolutions Inc and owns about 42,762 shares of Emergent BioSolutions Inc (EBS) stock worth over $108,188. Details can be seen in Louis W Sullivan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Louis W Sullivan has not made any transactions after 2023-02-01 and currently still holds the listed stock(s).

Transaction Summary of Louis W Sullivan

To

Louis W Sullivan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Louis W Sullivan owns 7 companies in total, including Emergent BioSolutions Inc () , United Therapeutics Corp () , and Henry Schein Inc () among others .

Click here to see the complete history of Louis W Sullivan’s form 4 insider trades.

Insider Ownership Summary of Louis W Sullivan

Ticker Comapny Transaction Date Type of Owner
Emergent BioSolutions Inc 2020-09-02 director
United Therapeutics Corp 2023-02-01 director
Henry Schein Inc 2016-03-02 director
ANI Pharmaceuticals Inc 2003-07-17 director
3M Co 2003-06-12 director
Bristol-Myers Squibb Co 2003-06-30 director
Equifax Inc 2003-06-30 director

Louis W Sullivan Latest Holdings Summary

Louis W Sullivan currently owns a total of 3 stocks. Among these stocks, Louis W Sullivan owns 12,180 shares of United Therapeutics Corp (UTHR) as of February 1, 2023, with a value of $3 Million and a weighting of 57.47%. Louis W Sullivan owns 25,986 shares of Henry Schein Inc (HSIC) as of March 2, 2016, with a value of $2 Million and a weighting of 40.31%. Louis W Sullivan also owns 42,762 shares of Emergent BioSolutions Inc (EBS) as of September 2, 2020, with a value of $108,188 and a weighting of 2.22%.

Latest Holdings of Louis W Sullivan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UTHR United Therapeutics Corp 2023-02-01 12,180 229.74 2,798,233
HSIC Henry Schein Inc 2016-03-02 25,986 75.52 1,962,463
EBS Emergent BioSolutions Inc 2020-09-02 42,762 2.53 108,188

Holding Weightings of Louis W Sullivan


Louis W Sullivan Form 4 Trading Tracker

According to the SEC Form 4 filings, Louis W Sullivan has made a total of 6 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in United Therapeutics Corp is the sale of 700 shares on February 1, 2023, which brought Louis W Sullivan around $182,931.

According to the SEC Form 4 filings, Louis W Sullivan has made a total of 0 transactions in Henry Schein Inc (HSIC) over the past 5 years. The most-recent trade in Henry Schein Inc is the sale of 23,470 shares on March 2, 2016, which brought Louis W Sullivan around $2 Million.

According to the SEC Form 4 filings, Louis W Sullivan has made a total of 2 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Emergent BioSolutions Inc is the sale of 28,418 shares on September 2, 2020, which brought Louis W Sullivan around $3 Million.

Insider Trading History of Louis W Sullivan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Louis W Sullivan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Louis W Sullivan Ownership Network

Ownership Network List of Louis W Sullivan

No Data

Ownership Network Relation of Louis W Sullivan


Louis W Sullivan Owned Company Details

What does Emergent BioSolutions Inc do?

Who are the key executives at Emergent BioSolutions Inc?

Louis W Sullivan is the director of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .

Emergent BioSolutions Inc () Insider Trades Summary

Over the past 18 months, Louis W Sullivan made no insider transaction in Emergent BioSolutions Inc (). Other recent insider transactions involving Emergent BioSolutions Inc () include a net sale of 3,530 shares made by Kathryn C Zoon , and a net sale of 1,912 shares made by Ronald Richard .

In summary, during the past 3 months, insiders sold 0 shares of Emergent BioSolutions Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,442 shares of Emergent BioSolutions Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,442 shares.

Emergent BioSolutions Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Emergent BioSolutions Inc Insider Transactions

No Available Data

Louis W Sullivan Mailing Address

Above is the net worth, insider trading, and ownership report for Louis W Sullivan. Currently GuruFocus does not have mailing address information for Louis W Sullivan.

Discussions on Louis W Sullivan

No discussions yet.